IGM Biosciences, Inc. IGMS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

43/100

2/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour IGM Biosciences, Inc. (IGMS), dont 25 achats et 25 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $19.26M.

Les initiés notables ayant une activité récente comprennent Decker Lisa Lynn, Tahir Misbah, Weber Steven. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — IGMS

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2025-06-16	Decker Lisa Lynn	Chief Business Officer	Vente Informative	951	$1.20	$1.14K	72,578
2025-06-16	Tahir Misbah	Chief Financial Officer	Vente Informative	1,522	$1.20	$1.83K	178,802
2025-06-16	Weber Steven	Principal Accounting Officer	Vente Informative	486	$1.20	$582.81	26,530
2025-06-16	Harler Mary Beth	Chief Executive Officer	Vente Informative	1,522	$1.20	$1.83K	338,181
2025-05-14	Weber Steven	Principal Accounting Officer	Vente Informative	1,865	$1.12	$2.09K	27,016
2025-03-31	Behrens M Kathleen	Director	Attribution de RSU	1,471	-	-	20,751
2025-03-31	Baker Bros. Advisors Lp	10 Percent Owner	Attribution de RSU	953	-	-	356,095
2025-03-31	Redmile Group, Llc	10 Percent Owner	Attribution de RSU	828	-	-	2,964,015
2025-03-31	Lee Michael Stewart	Director	Attribution de RSU	828	-	-	11,884
2025-03-31	Topsoe Jakob Haldor	10 Percent Owner	Attribution de RSU	828	-	-	90,884
2025-03-31	Topsoe Christina Teng	10 Percent Owner	Attribution de RSU	1,284	-	-	52,951
2025-03-31	Thompson Elizabeth H.z.	Director	Attribution de RSU	694	-	-	6,502
2025-03-14	Decker Lisa Lynn	Chief Business Officer	Vente Informative	4,512	$1.23	$5.55K	73,529
2025-03-14	Tahir Misbah	Chief Financial Officer	Vente Informative	7,329	$1.23	$9.01K	180,324
2025-03-14	Weber Steven	Principal Accounting Officer	Vente Informative	1,701	$1.23	$2.09K	28,881
2025-03-14	Harler Mary Beth	Chief Executive Officer	Vente Informative	7,329	$1.23	$9.01K	339,703
2025-01-15	Weber Steven	Principal Accounting Officer	Vente Informative	1,122	$1.70	$1.91K	30,582
2024-12-31	Redmile Group, Llc	10 Percent Owner	Attribution de RSU	1,734	-	-	2,963,187
2024-12-31	Lee Michael Stewart	Director	Attribution de RSU	1,734	-	-	11,056
2024-12-31	Behrens M Kathleen	Director	Attribution de RSU	3,078	-	-	19,280
2024-12-31	Baker Bros. Advisors Lp	10 Percent Owner	Attribution de RSU	1,994	-	-	355,142
2024-12-31	Topsoe Jakob Haldor	10 Percent Owner	Attribution de RSU	1,734	-	-	90,056
2024-12-31	Topsoe Christina Teng	10 Percent Owner	Attribution de RSU	2,687	-	-	51,667
2024-12-31	Thompson Elizabeth H.z.	Director	Attribution de RSU	1,452	-	-	5,808
2024-12-16	Decker Lisa Lynn	Chief Business Officer	Vente Informative	1,063	$7.48	$7.95K	78,041
2024-12-16	Tahir Misbah	Chief Financial Officer	Vente Informative	1,708	$7.48	$12.78K	187,653
2024-12-16	Weber Steven	Principal Accounting Officer	Vente Informative	539	$7.48	$4.03K	31,704
2024-12-16	Harler Mary Beth	Chief Executive Officer	Vente Informative	1,708	$7.48	$12.78K	347,032
2024-11-18	Tahir Misbah	Chief Financial Officer	Attribution de RSU	66,667	-	-	189,361
2024-11-07	Weber Steven	Principal Accounting Officer	Attribution de RSU	6,700	-	-	32,243
2024-10-02	Harler Mary Beth	Chief Executive Officer	Attribution de RSU	185,000	-	-	348,740
2024-09-30	Behrens M Kathleen	Director	Attribution de RSU	3,078	-	-	16,202
2024-09-30	Baker Bros. Advisors Lp	10 Percent Owner	Attribution de RSU	1,994	-	-	353,148
2024-09-30	Redmile Group, Llc	10 Percent Owner	Attribution de RSU	1,734	-	-	3,081,800
2024-09-30	Lee Michael Stewart	Director	Attribution de RSU	1,734	-	-	9,322
2024-09-30	Topsoe Jakob Haldor	10 Percent Owner	Attribution de RSU	1,734	-	-	88,322
2024-09-30	Topsoe Christina Teng	10 Percent Owner	Attribution de RSU	2,687	-	-	48,980
2024-09-30	Thompson Elizabeth H.z.	Director	Attribution de RSU	1,452	-	-	4,356
2024-09-13	Takimoto Chris H	Chief Medical Officer	Vente Informative	1,487	$11.54	$17.16K	154,331
2024-09-13	Decker Lisa Lynn	Chief Business Officer	Vente Informative	925	$11.54	$10.67K	79,104
2024-09-13	Tahir Misbah	Chief Financial Officer	Vente Informative	1,487	$11.54	$17.16K	122,694
2024-09-13	Schwarzer Fred	CEO and President	Vente Informative	3,946	$11.54	$45.53K	250,124
2024-09-13	Keyt Bruce	Chief Scientific Officer	Vente Informative	1,487	$11.54	$17.16K	242,948
2024-09-13	Weber Steven	Principal Accounting Officer	Vente Informative	469	$11.54	$5.41K	25,543
2024-09-13	Harler Mary Beth	Head, Research & Autoimmunity	Vente Informative	1,487	$11.54	$17.16K	163,740
2024-08-08	Strohl William	Director	Attribution de RSU	125,000	-	-	125,000
2024-07-25	Hambleton Julie	Director	Exercice d'Options (Vente)	15,132	$1.39	$21.03K	-
2024-07-19	Takimoto Chris H	Chief Medical Officer	Restitution d'Actions	150,000	$68.01	$10.2M	-
2024-07-19	Decker Lisa Lynn	Chief Business Officer	Restitution d'Actions	60,000	$86.24	$5.17M	-
2024-07-19	Tahir Misbah	Chief Financial Officer	Restitution d'Actions	40,000	$91.50	$3.66M	-

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration